Mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) is a dual-speci®city protein phosphatase encoded by an immediate-early gene responsive to growth factors and stress. The MKP-1 protein selectively inactivates MAP kinases in vitro by dephosphorylation of the regulatory Thr and Tyr residues. Little is known on the mechanisms that regulate MKP-1 gene expression. Here, we demonstrate that Ca 2+ is both necessary and sucient for the induction of MKP-1 gene expression. Treatment of Rat1 ®broblasts with the Ca 2+ chelating agent BAPTA completely suppressed serum-induced MKP-1 expression in a dose-and timedependent manner. The inhibitory eect of BAPTA was observed at the level of the protein and the mRNA. Importantly, Ca 2+ chelation blocked the induction of MKP-1 expression in response to all stimuli tested and in dierent cell types. Increasing the intracellular concentration of Ca 2+ with the ionophore A23187 was sucient to induce MKP-1 mRNA and protein expression in rat ®broblasts. We also provide evidence that activation of MAP kinases is not an absolute requirement for induction of the MKP-1 gene. Exposure of rat ®broblasts to A23187 induced MKP-1 expression without activating the JNK and p38 MAP kinase pathways. Also, inhibition of the ERK pathway with the selective MEK inhibitor PD98059 did not interfere with serumstimulated MKP-1 mRNA expression. These results will help de®ne the regulatory mechanisms that govern MKP-1 gene transcription in target cells.
Introduction
Mitogen-activated protein (MAP) kinases are a family of proline-directed serine/threonine kinases which play a key role in transducing signals from a wide range of extracellular stimuli into intracellular responses. Three distinct subfamilies of MAP kinases are currently known in vertebrates: the extracellular signal-regulated kinases (ERKs), the stress-activated protein (SAP)/Jun N-terminal kinases (JNKs), and p38 (reviewed in Cano and Mahadevan, 1995; Cobb and Goldsmith, 1995) ). The ERK isoforms ERK1/ERK2 are activated in response to mitogenic and differentiation factors (Cobb et al., 1991; L'Allemain, 1994) , whereas JNKs and p38 respond mainly to environmental stress and proin¯ammatory cytokines (Kyriakis et al., 1994; Han et al., 1994; Rouse et al., 1994; Raingeaud et al., 1995; Force et al., 1996) . The activation of MAP kinases is mediated by a family of dual-speci®city enzymes, called MAP kinase kinases, which phosphorylate the proteins on both threonine and tyrosine residues within the sequence T-X-Y (Cobb and Goldsmith, 1995; Waskiewicz and Cooper, 1995) . On the other hand, much less is known on the mechanisms leading to inactivation of MAP kinases.
Recently, a novel family of dual-speci®city protein phosphatases capable of dephosphorylating the regulatory threonine and tyrosine residues of MAP kinases has been described (reviewed in Keyse, 1995) . All these enzymes bear the characteristic active-site motif of protein tyrosine phosphatases (PTPs) and display sequence homology to the vaccinia virus VH1 phosphatase (Guan et al., 1991) . The ®rst mammalian gene of this family to be discovered was mouse 3CH134 (also known as erp) and its human homologue CL100 (also known as hVH-1) which was isolated as an immediate-early gene inducible by growth factors and stress (Charles et al., 1992; Keyse and Emslie, 1992; Noguchi et al., 1993; Zheng and Guan, 1993) . Recombinant 3CH134/CL100 puri®ed from bacteria preferentially dephosphorylates the phosphothreonine and phosphotyrosine residues of MAP kinases in vitro resulting in their inactivation Alessi et al., 1993; Zheng and Guan, 1993) . Overexpression of 3CH134 in COS cells leads to dephosphorylation and inactivation of ERK1/ ERK2; and catalytically-inactive 3CH134 physically associates with the phosphorylated form of ERK1/ ERK2 in intact cells . On the basis of these results, the 3CH134/CL100 phosphatase was renamed MAP kinase phosphatase-1 (MKP-1). The expression of MKP-1 was further shown to inhibit ERK-dependent reporter gene activity (Sun et al., 1994b; Brondello et al., 1995) , to block cell cycle progression and entry into S phase of ®broblast cells (Noguchi et al., 1993; Sun et al., 1994b; Brondello et al., 1995) and to prevent PC12 cell dierentiation (Fukuda et al., 1995) . All these observations suggest that MKP-1 might be a physiological MAP kinase phosphatase, but its relative contribution to the inactivation of MAP kinases in speci®c cellular processes in vivo remains to be established.
Other members of the VH1 family of dual-speci®city protein phosphatases include VHR (Ishibashi et al., 1992) , PAC-1 (Rohan et al., 1993) , MKP-2/hVH-2/ TYP-1 (Guan and Butch, 1995; Misra-Press et al., 1995; King et al., 1995) , B23/hVH-3 (Ishibashi et al., 1994; Kwak et al., 1995) , hVH-5 (Martell et al., 1995) and rVH-6/MKP-3 (Mourey et al., 1996; Muda et al., 1996) . These gene products have unique but overlapping tissue distribution patterns. Like MKP-1, all the enzymes exhibit activity towards phosphorylated ERK1/ERK2 in vitro. Moreover, in vivo expression of PAC-1, MKP-2, and MKP-3 interferes with growth factor-dependent phosphorylation and enzymatic activation of ERK1/ERK2 (Ward et al., 1994; King et al., 1995; Muda et al., 1996; Chu et al., 1996) . Interestingly, recent results obtained in transient transfection experiments suggest that individual MAP kinase phosphatases may have distinct speci®cities for the ERK, JNK and p38 MAP kinases (Chu et al., 1996) .
Little is known on the mechanisms by which growth factors and stress activate transcription of the gene encoding MKP-1. The induction of MKP-1 mRNA expression has been observed in several cell types in response to stimuli as diverse as growth and dierentiation factors, cAMP-elevating agents, phorbol esters, heat shock, oxidative stress, and genotoxic agents (Charles et al., 1992; Keyse and Emslie, 1992; Noguchi et al., 1993; Du et al., 1993; Liu et al., 1995) . The aim of this study was to characterize the signalling pathways involved in the regulation of MKP-1 expression. We demonstrate that calcium is both necessary and sucient for MKP-1 gene expression in ®broblast and smooth muscle cells. Moreover, we provide strong evidence that the three MAP kinases, ERKs, JNKs and p38, are not obligatory components of the pathways leading to transcription of the MKP-1 gene in ®broblast cells.
Results

Calcium is necessary for induction of MKP-1 gene expression
To determine whether MKP-1 expression is controlled by reversible protein phosphorylation, we ®rst examined the eect of two non selective protein kinase inhibitors, 2-aminopurine and K-252a (Mahadevan et al., 1990; Kase et al., 1987) , on serum-induced expression of MKP-1. Growth-arrested Rat1 fibroblasts were pre-treated for 30 min with increasing concentrations of 2-aminopurine or K-252a and then stimulated for 90 min with 10% calf serum. Cell lysates were prepared and the expression of MKP-1 was analysed by immunoblotting using a speci®c antibody. Both inhibitors signi®cantly reduced MKP-1 protein expression in a dose-dependent manner (Figure 1 ). K252a was more potent than 2-aminopurine with a maximal inhibitory eect observed at 30 nM. In a complementary experiment, we also found that phloretin, an uncoupler and inhibitor of mitochondrial oxidative phosphorylation which depletes cellular stores of ATP (De Jonge et al., 1983) , completely abolished the serum-dependent expression of MKP-1 in Rat1 cells (data not shown). These results strongly implicate the action of protein kinase(s) in the regulation of MKP-1 expression.
To gain insights into the nature of the protein kinase(s) involved, we evaluated the eect of selective inhibitors of protein kinase C (PKC) isoforms, tyrosine kinase inhibitors and a membrane-permeable Ca 2+ chelating agent on serum-induced expression of MKP-1. CGP41251 is a compound which inhibits Ca 2+ -dependent and independent isoforms of PKC (Meyer et al., 1989; Marte et al., 1994) , while Go6976 is more selective for the classical Ca 2+ -dependent PKC isoforms (Martiny-Baron et al., 1993) . As shown in Figure 2a , the two PKC inhibitors, and the biologically inactive analog CGP42700, had no eect on the phosphatase expression level. Similarly, genistein and herbimycin A, two broad spectrum tyrosine kinase inhibitors (Akiyama et al., 1987; Uehara et al., 1989) , did not modify the eect of serum on MKP-1 expression (Figure 2b Figure 1 . The concentrations of drug inhibitors were: 10 mM BAPTA, 10 mM CGP41251, 10 mM CGP42700, 10 mM Go6976, 30 mM genistein (Gen) and 0.5 mM herbimycin A (HA) a complete inhibition of the serum-dependent expression of MKP-1. These results prompted us to investigate the eect of BAPTA in more detail. Pharmacological studies revealed that BAPTA inhibits MKP-1 expression in a dose-dependent manner with a half-maximal inhibition observed at a concentration of approximately 1 mM (Figure 3a) . A complete inhibition was observed at 10 mM BAPTA. Time-course experiments indicated that addition of BAPTA 60 or 30 min before serum induced a total inhibition of MKP-1 expression (Figure 3b ). When the chelating agent was added together with serum, only a partial inhibition was observed. The inhibitory eect was further reduced when BAPTA was added 30 min after serum stimulation, and completely disappeared at 60 min. BAPTA also reduced the rate of protein synthesis at this concentration, which may partly account for the eect seen on MKP-1 protein levels (data not shown). In order to determine if the involvement of Ca 2+ was speci®c to the stimulus and/or the cellular context, we examined the eect of BAPTA on two dierent cell types, Rat1 ®broblasts and rat aortic smooth muscle cells (SMC), treated with various extracellular stimuli. As shown in Figure 4a , MKP-1 protein expression was strongly induced by serum in Rat1 ®broblasts, but also in response to epidermal growth factor, thrombin, phorbol esters, and heat shock. Preincubation of the cells with BAPTA completely abolished MKP-1 expression, whatever the stimulus used. The same experiment was performed in rat aortic SMC using the same stimuli, except for thrombin which was substituted by angiotensin II. As observed for Rat1 cells, MKP-1 expression was induced by all treatments and the response was blocked by BAPTA ( Figure 4b ).
Since MKP-1 is encoded by an immediate-early gene, it was of interest to determine if the eect of BAPTA is exerted at the transcriptional level. Rat1 ®broblasts were pretreated in the absence or presence of BAPTA before serum stimulation and the level of MKP-1 mRNA was analysed by Northern blotting. As expected, serum rapidly and strongly increased the expression of MKP-1 mRNA, which reached a maximal level at 30 min and declined thereafter ( Figure 5 ). In the presence of BAPTA, the induction of MKP-1 mRNA expression was almost completely abolished.
Increased calcium concentration is sucient to induce MKP-1 gene expression
Together, the preceding results indicated that Ca 2+ is required for MKP-1 gene expression. We then wanted to determine if an increase in the intracellular concentration of Ca 2+ alone was sucient to activate the MKP-1 gene. Rat1 ®broblasts were treated with the Ca 2+ ionophore A23187 and the level of MKP-1 expression was monitored as above. As shown in Figure 6a , addition of A23187 increased the expression of MKP-1 protein in a dose-dependent manner with a maximal eect observed at 3 mM. Time-course experiments revealed that A23187-induced MKP-1 expression reaches a maximum at approximately 2 h and slowly declines thereafter (Figure 6b The cells were then exposed to the following stimuli: medium (cont), 10% calf serum (CS) for 90 min, 100 ng/ml epidermal growth factor (EGF) for 90 min, 3 U/ml thrombin (Thr) for 90 min, 100 nM PMA for 90 min, 100 nM angiotensin II (AII) for 90 min and heat shock at 428C for 30 min followed by 60 min at 378C (HS). The expression of MKP-1 protein was analysed by immunoblotting as described in Figure 1 compared to serum. This suggests that additional signalling pathways might be required for full transcriptional activation of the MKP-1 gene.
Induction of MKP-1 gene expression in the absence of MAP kinases activation
We also performed a series of experiments to investigate if MAP kinases, which are putative substrates of the phosphatase, are required for the induction of MKP-1 expression in response to extracellular signals. Indeed, it has been recently proposed that activation of the JNK pathway induces MKP-1 gene transcription in NIH3T3 cells (Bokemeyer et al., 1996) . We ®rst measured the enzymatic activity of JNK2, ERK1, and p38 in Rat1 cells following stimulation with A23187. Ca 2+ in¯ux caused a strong activation of ERK1, which reached a maximum at approximately 15 min (eightfold stimulation) and remained elevated for at least 2 h (Figure 7b ). In contrast, addition of A23187 did not activate JNK2 and only had a weak (twofold) and transient stimulatory eect on p38 activity (Figure 7c and 7a) interfering with the upstream activation of the MAP kinase kinases MEK1/MEK2 Alessi et al., 1995; Servant et al., 1996) . Incubation of Rat1 cells with 50 mM PD98059 resulted in little inhibition of MKP-1 protein expression in response to 10% serum (Figure 8b ). However, in the presence of high serum concentration, PD98059 was found to only partially block the activation of ERK1 (Figure 8a ). Other workers also reported that PD98059 does not inhibit the activation of ERK1/ERK2 completely when cells are stimulated with high concentrations of agonists (Alessi et al., 1995; Flynn and Proud, 1996) . Thus, to further evaluate the involvement of ERK1/ERK2 in the regulation of MKP-1 expression, we tested the eect of PD98059 at sub-optimal serum concentration. When Rat1 cells were stimulated with 1% serum, PD98059 completely suppressed the activation of ERK1 and, under these conditions, partially inhibited the expression of MKP-1 protein (Figure 8a and b) . However, PD98059 had no signi®cant eect on the accumulation of MKP-1 mRNA in these cells (Figure 8c ). It is important to underline that PD98059 inhibits growth factor-induced protein synthesis at this concentration (Servant et al., 1996) , which may explain the decrease in MKP-1 protein. These results argue that activation of MAP kinases is not an absolute requirement for the induction of MKP-1 gene transcription by extracellular stimuli.
Discussion
MKP-1 is an immediate-early gene that is rapidly and transiently induced in response to growth factors and cellular stress. The MKP-1 gene encodes a VH1-like dual-speci®city phosphatase which exhibits catalytic activity towards MAP kinases in vitro. Little is known about the mechanisms that regulate MKP-1 gene expression and about the physiological roles of the enzyme. In this study, we show that in ®broblast cells: (1) Ca 2+ is both necessary and sucient for the induction of MKP-1 gene expression; and (2) is a widespread second messenger which participates to a host of cellular changes including gene expression (Clapham, 1995) . Elevation of intracellular Ca 2+ levels has been shown to activate transcription of a number of eukaryotic genes through phosphorylation of transcription factors that bind to the CRE (cAMPresponsive element) (Sheng et al., 1990; Dash et al., 1991; Liu et al., 1993) . This eect of Ca 2+ may be mediated by the multifunctional Ca 2+ /calmodulindependent protein kinases (Schulman, 1993) which can phosphorylate and activate dierent members of the CRE-binding protein (CREB)/activating transcription factor (ATF) family, such as CREB, CREMt and ATF-1 (Dash et al., 1991; Sheng et al., 1991; Shimomura et al., 1996; de Groot et al., 1993; Sun et al., 1994c) . In T lymphocytes, the activation of nuclear factor of activated T cells (NF-AT) is quantitatively correlated with the intracellular concentration of Ca 2+ (Negulescu et al., 1994) . The in¯ux of Ca 2+ through voltage-sensitive Ca 2+ channels also stimulates serum response factor (SRF)-dependent transcription in the pheochromocytoma cell line PC12 (Miranti et al., 1995) . Sequencing of the 5'¯anking region of the mouse MKP-1 gene revealed the presence of several consensus sequences that include one CRE, two SP1 sites, two CTF/NF1-like sites, and one E-box motif (Noguchi et al., 1993) . The human MKP-1 gene is alsō anked by two CREs (Kwak et al., 1994) . In contrast to other immediate-early genes, no serum response element (SRE) has been found. Although the role of these dierent elements in the transcriptional activation of MKP-1 remains to be determined, it is tempting to speculate that the CRE may mediate the response to Ca 2+ . In support of this hypothesis, cAMP was found to strongly induce MKP-1 mRNA expression in NIH3T3 cells (Noguchi et al., 1993) .
The expression of MKP-1 mRNA is induced by a range of stimuli that also trigger the activation of MAP kinase pathways in mammalian cells. This suggests that MAP kinase activity may be required for MKP-1 transcription, thereby providing a feedback loop to inactivate the signalling pathway (Sun and Tonks, 1994a) . In ®ssion yeast, activation of the stressactivated MAP kinase Spc1/Sty1 leads to expression of the pyp2 + gene in a manner dependent upon the Atf1 transcription factor (Millar et al., 1995; Shiozaki and Russel, 1996; Wilkinson et al., 1996) . The pyp2 + gene encodes a tyrosine-speci®c protein phosphatase which dephosphorylates Spc1/Sty1 in a feedback inhibition loop. Recently, Grumont et al. (1996) have provided evidence suggesting that ERK2 activation is necessary for phorbol esters and v-Ras-dependent transcription of the Pac-1 gene in T lymphocytes. In another study, Bokemeyer et al. (1996) reported that expression of an active mutant of MEK kinase-1 in NIH3T3 cells leads to MKP-1 gene induction. However, the ®ndings reported in this study together with observations by other groups suggest that MAP kinases are not obligatory components of the signalling pathways that regulate MKP-1 gene expression. We have found that exposure of rat ®broblasts to the Ca 2+ ionophore A23187 induces MKP-1 mRNA expression without signi®cantly activating the JNK and p38 MAP kinase pathways. Moreover, treatment with SB203580, a highly selective inhibitor of p38 MAP kinase , had little or no eect on the induction of MKP-1 expression by serum (data not shown). We also show that incubation of rat ®broblasts with a concentration of PD98059 that blocks ERK1/ERK2 activation does not interfere with serum-stimulated MKP-1 mRNA expression. The observation that PD98059 partly inhibits MKP-1 protein expression most likely re¯ects the inhibitory eect of the compound on protein synthesis. Indeed, we have recently demonstrated that addition of PD98059 (Servant et al., 1996) or expression of a dominantnegative mutant of ERK1 (Gopalbhai K and Meloche S, unpublished data) block growth factor-stimulated protein synthesis in target cells.
Other studies also reported a lack of correlation between the activation of MAP kinases and the induction of MKP-1 gene transcription in various cell types. For example, treatment of B lymphocytes (Mittelstadt and DeFranco, 1993) or NIH3T3 cells (Bokemeyer et al., 1996) with phorbol esters was found to stimulate the phosphorylation of ERK isoforms without inducing MKP-1 gene expression. Also, expression of a constitutively-active MEK1 mutant failed to increase MKP-1 mRNA expression in NIH3T3 cells, whereas a dominant-negative form of the kinase potentiated serum or anisomycin-induced MKP-1 gene expression (Bokemeyer et al., 1996) . In HeLa cells, treatment with the genotoxic agent methyl methanesulfonate strongly induced MKP-1 mRNA expression but had little eect on ERK1/ERK2 activity (Liu et al., 1995) . In murine macrophages expressing an oncogenic DRaf-1: estrogen receptor (DRaf-1-ER) fusion protein, the MKP-1 gene was shown to be induced in response to lipopolysaccharide stimulation but not in response to activation of DRaf-1-ER with estradiol, despite the rapid and prolonged activation of ERK1/ERK2 (Hambleton et al., 1995) . Finally, treatment of Rat1 cells with the PKC inhibitor Ro-31-8220 was recently reported to activate the JNK pathway, but to inhibit growth factor-stimulated expression of MKP-1 (Beltman et al., 1996) . Taken together, these observations indicate that activation of signalling pathways other than the three known MAP kinase modules is required for full transcription of the MKP-1 gene.
Materials and methods
Materials and antibodies
Tissue culture reagents and epidermal growth factor were purchased from Life Technologies. Thrombin, 2-aminopurine, bovine myelin basic protein (MBP), anisomycin, and protease inhibitors were from Sigma. Angiotensin II was obtained from Hukabel Scienti®c. Phorbol 12-myristate 13-acetate (PMA), K-252a, and genistein were from LC Services. BAPTA
(1,2-bis(o-aminophenoxy) ethane-N,N,N',N-tetraacetic acid tetra (acetoxymethyl) ester) and A23187 were from Calbiochem. Go6976 and herbimycin A were from Biomol. CGP41251 and the biologically inactive analogue CGP42700 were gifts from Ciba-Geigy.
[g-32 P]ATP was from Amersham Corp. PD98059 was a gift from Parke-Davis. The bacterial expression plasmids encoding GST-ATF2 and GST-c-Jun were kindly provided by Dr Roger Davis (University of Massachussets) and Dr Jim Woodgett (Ontario Cancer Institute), respectively. The recombinant fusion proteins were expressed in E. coli and puri®ed as described (Guan and Dixon, 1991b) .
The anti-MKP-1 polyclonal antibody was obtained from Santa-Cruz Biotechnology. Antiserum SM1 has been described and speci®cally immumoprecipitates ERK1 isoform (Meloche, 1995) . The polyclonal antibodies to JNK2 and p38 were generously provided by Dr Jacques Landry (UniversiteÂ Laval).
Cell culture
Rat1 cells were cultured in minimum essential medium (MEM) supplemented with 10% calf serum, 2 mM glutamine and antibiotics (Meloche, 1995) . They were made quiescent by incubation in serum-free Dulbecco's modi®ed Eagle's medium (DMEM)/F12 (1 : 1) containing 15 mM HEPES (pH 7.4) and 1 mg/ml BSA for 24 h. Rat aortic SMC were cultured and synchronized as described previously (Giasson and Meloche, 1995) .
Immunoblot analysis of MKP-1
Following stimulation with the indicated agents, the cells were washed twice with ice-cold phosphate-buered saline (PBS) and lysed in Triton X-100 lysis buer (50 mM TrisHCl, pH 7.4, 100 mM NaCl, 50 mM sodium¯uoride, 5 mM EDTA, 40 mM b-glycerophosphate, 1 mM sodium orthovanadate, 10 74 M phenylmethylsulfonyl¯uoride, 10 76 M leupeptin, 10 76 M pepstatin A, 1% Triton X-100). After 25 min at 48C, the lysates were clari®ed by centrifugation at 13 0006g for 10 min at 48C. Equal amounts of lysate proteins (100 mg) were subjected to SDS-gel electrophoresis on 10% acrylamide gels and transferred to Hybond-C nitrocellulose membranes (Amersham) in 25 mM Tris, 192 mM glycine. Membranes were blocked in Tris-buffered saline (TBS) containing 5% non-fat dry milk and 0.05% Tween-20 for 45 min at 378C prior to incubation for 60 min at room temperature with anti-MKP-1 antibody (1 mg/ml) in blocking solution. The membranes were washed three times in TBS containing 0.05% Tween-20 (TBST) prior to incubation for 30 min at room temperature with horseradish peroxidase-conjugated goat antirabbit IgG diluted 1 : 10 000 in blocking solution. After washing as above, the immunoreactive bands were visualized by enhanced chemiluminescence (Amersham).
Protein kinase assays
The enzymatic activity of JNK2, ERK1 and p38 was measured by speci®c immune complex kinase assays using GST-c-Jun, MBP and GST-ATF2 as substrates, respectively. The assay of ERK1/ERK2 has been described previously (Meloche, 1995; Giasson and Meloche, 1995) . For JNK2 assays, cell lysates were prepared as described above and 500 mg of proteins were incubated for 2 h at 48C with 2 ml of anti-JNK2 antibody preadsorbed to protein ASepharose (Pharmacia) beads. The immune complexes were washed three times with lysis buer and once with JNK assay buer (20 mM HEPES, pH 7.4, 20 mM MgCl 2 , 2 mM dithiothreitol (DTT), 20 mM b-glycerophosphate, 100 mM sodium orthovanadate). The beads were then resuspended in 40 ml of JNK assay buer containing 1 mg GST-c-Jun, 50 mM ATP and 5 mCi [g-32 P]ATP. The reaction was initiated with ATP, incubated at 308C for 15 min, and stopped by addition of 26Laemmli's sample buer. The samples were analysed by SDS-gel electrophoresis and autoradiography.
For p38 assays, 150 mg of lysate proteins were incubated for 2 h at 48C with 5 ml of anti-p38 antibody coupled to protein A-Sepharose. The immune complexes were washed as above. The beads were then resuspended in 20 ml of p38 kinase assay buer (25 mM HEPES, pH 7.4, 25 mM MgCl 2 , 2 mM DTT, 25 mM b-glycerophosphate, 100 mM sodium orthovanadate) containing 1 mg GST-ATF2, 50 mM ATP, and 3 mCi [g-32 P]ATP. The enzymatic reaction was carried out at 308C for 30 min and analysed as described for JNK2.
Northern blot analysis
Total RNA was extracted by a modi®ed version of the guanidinium thyocyanate procedure as described (Chomczinzki and Sacchi, 1987; Chomczynski, 1993) . Equal amounts of total RNA (15 ± 25 mg) were denatured by heating for 15 min at 658C in 2.2 M formaldehyde and 50% formamide and resolved by electrophoresis in a 1% agarose gel containing 1.8% formaldehyde. The RNA were transferred to Hybond-N membranes (Amersham), ®xed, and hybridized with 32 P-labeled probes. Hybridization was carried out in hybridization medium [56SSC (16SSC=150 mM NaCl, 15 mM sodium citrate), 0.1% SDS, 56Denhardt's solution (16Denhardt's=0.02% Ficoll 400, 0.02% polyvinyl pyrrolidone and 0.02% bovine serum albumin), 50% formamide, and 100 mg/ml herring sperm DNA] containing the labeled probe (1 ± 2610 6 c.p.m./ml) for 16 h at 428C. The membranes were washed twice at 258C for 15 min in 26SSC, 0.1% SDS and twice at 608C for 30 min in 0.56SSC, 0.1% SDS. The extent of hybridization was analysed with a phosphorimager apparatus (Molecular Dynamics). The results were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. The probes used were: a 1.2 kb PvuII ± NotI fragment of human MKP-1 cDNA (provided by Dr Stephen Keyse, ICRF), and a 1.2 kb XbaI ± PstI fragment of rat GAPDH cDNA. All the probes were labeled by random priming.
Other methods
Protein concentrations were measured using the BCA protein assay kit (Pierce) with bovine serum albumin as standard.
